Purified anti-mouse/rat CD49e Antibody anti-CD49e - HMα5-1,BioLegend,103902

Additional reported applications (for the relevant formats) include: immunoprecipitation1,in vivoinhibition of fibronectin receptor (VLA-5) functions andin vitroblocking of CD49e mediated interactions1,2. The Ultra-LEAF™ Purified antibody (Endotoxin <0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103909 & 103910).

Host

Armenian Hamster

Reactivity

Mouse, Rat

Application

FC - Quality testedIP - Reported in the literature, not verified in house

Platform ID

BAB486523352

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-mouse/rat CD49e Antibody anti-CD49e - HMα5-1
Cat. No.103902
HostArmenian Hamster
RRIDAB_313059 (BioLegend Cat. No. 103902)
IsotypeArmenian Hamster IgG
ReactivityMouse, Rat
ApplicationFC - Quality testedIP - Reported in the literature, not verified in house
ClonalityMonoclonal
Clone NumberHMα5-1
Concentration0.5 mg/ml
TargetCD49e
ImmunogenAffinity-Purified mouse VLA-5 protein (α5β1, CD49e/CD29)
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

CD49e is a 135 kD protein, also known as α5integrin or VLA-5 α chain. It is a member of the integrin family, expressed on thymocytes, pro-B cells, activated T cells, and mast cells. CD49e associates with CD29 (integrin β1chain) to form the fibronectin receptor (VLA-5). CD49e plays a critical role in both adhesion and T cell costimulation. The primary ligand for CD49e/CD29 (VLA-5) is fibronectin. The HMα5-1 antibody has been shown to partially block CD49e mediated interactions. It has also been observed that plate-bound HMα5-1 antibody enhances IgE mediated degranulation and thatin vivoinjection of HMα5-1 antibody, in combination with anti-CD49d and anti-CD61 antibodies, blocks passive cutaneous anaphylaxis.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.